Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient

Journal of Alzheimer's Disease : JAD
K Le GuennecG Nicolas

Abstract

Heterozygous SORL1 protein truncating variants (PTV) are a strong risk factor for early-onset Alzheimer's disease (EOAD). In case control studies performed at the genome-wide level, PTV definition is usually straightforward. Regarding splice site variants, only those affecting canonical sites are typically included. Some other variants, not annotated as PTV, could, however, affect splicing and hence result in a loss of SORL1 function. We took advantage of the whole exome sequencing data from the 9/484 patients with a previously reported SORL1 PTV in the French EOAD series and searched for a second variant which may affect splicing and eventually result in more than 50% loss of function overall. We found that one patient, known to carry a variant predicted to disrupt the canonical 5' splice site of exon 8, also carried a second novel intronic variant predicted to affect SORL1 splicing of exon 29. Segregation analysis showed that the second variant was located in trans from the known PTV. We performed ex vivo minigene splicing assays and showed that both variants led to the generation of transcripts containing a premature stop codon. This is therefore the first evidence of a human carrying biallelic SORL1 PTV. This patient had a ...Continue Reading

References

Sep 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Olav M AndersenThomas E Willnow
Jan 16, 2007·Nature Genetics·Ekaterina RogaevaPeter St George-Hyslop
Apr 5, 2012·Molecular Psychiatry·C PottierUNKNOWN PHRC GMAJ Collaborators
Apr 6, 2012·Journal of Alzheimer's Disease : JAD·David WallonUNKNOWN collaborators of GMAJ project
Nov 16, 2012·The New England Journal of Medicine·Thorlakur JonssonKari Stefansson
Nov 16, 2012·The New England Journal of Medicine·Rita GuerreiroUNKNOWN Alzheimer Genetic Analysis Group
Feb 6, 2013·Journal of Alzheimer's Disease : JAD·Cyril PottierDidier Hannequin
Feb 14, 2014·Science Translational Medicine·Safak CaglayanThomas E Willnow
Nov 11, 2014·Annals of Neurology·Badri N VardarajanRichard Mayeux
Mar 26, 2015·Nature Genetics·Stacy SteinbergKari Stefansson
Aug 26, 2015·Molecular Psychiatry·G NicolasUNKNOWN CNR-MAJ collaborators
Apr 3, 2016·Neurology·Kilan Le GuennecUNKNOWN CNR-MAJ collaborators
Aug 19, 2016·Nature·Monkol LekUNKNOWN Exome Aggregation Consortium
Nov 9, 2016·Neurology. Genetics·Michael L CuccaroMargaret A Pericak-Vance
Dec 14, 2016·Molecular Psychiatry·K Le GuennecA Rovelet-Lecrux
Dec 22, 2016·Human Heredity·Gaël NicolasDominique Campion
Mar 30, 2017·PLoS Medicine·Hélène-Marie LanoiseléeUNKNOWN collaborators of the CNR-MAJ project
May 26, 2017·European Journal of Human Genetics : EJHG·Henne HolstegePhilip Scheltens
Aug 10, 2017·Neurobiology of Aging·Céline BellenguezUNKNOWN CNR MAJ collaborators

❮ Previous
Next ❯

Citations

May 21, 2020·International Journal of Molecular Sciences·Eva BagyinszkySeongSoo A An
Mar 6, 2021·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Julie HoogmartensChristine Van Broeckhoven

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.